What is Summit Therapeutics's total revenue?

Summit Therapeutics (SMMT) reported total revenue of $0 in Q4 2024.

What is the long-term trend for Summit Therapeutics's total revenue?

Over 2 years (2021 to 2023), Summit Therapeutics's total revenue has grown at a -100.0% compound annual growth rate (CAGR), from $1.81M to $0.

Summit Therapeutics SMMT Total Revenue

Discontinued — last reported Q4 '24

Total Revenue at other companies

Merck & Co.MRK

$16.29B+4.9%

ExelixisEXEL

$610.81M+10.0%

IncyteINCY

$1.27B+20.9%

Bristol-Myers SquibbBMY

$11.49B+2.6%

AbbVieABBV

$15B+12.4%

Jazz PharmaceuticalsJAZZ

$1.07B+19.1%

Other financials

Income statement

See full

Operating income-$65.6M-81.2%

Net income-$189.4M-201%

EPS (diluted)-$0.24-167%

Balance sheet

See full

Cash & equivalents$8.2M+7.2%

Total debt$20.0M+211%

Total equity$545.9M+58.5%

Total assets$647.9M+68.8%

Cash flow

See full

Operating cash flow-$122.3M-99.9%

CapEx$245.0K-41.9%

Free cash flow-$122.5M-99.0%

Valuation

See full

Market cap$10.67B+3.3%

Enterprise value$10.68B+3.4%

Profitability

See full

Operating margin-268,266.8%-272,316pp

Net margin-271,685%-275,966pp

FCF margin-5,931.6%+4,730pp

Returns & leverage

See full

Return on equity-271%-1,725pp

Debt / equity0×0.0×

Current ratio7.4×-3.2×

Where this comes from

Reported directly by Summit Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Summit Therapeutics’s 10-K, filed February 24, 2025, on SEC EDGAR. View the filing →

Ask your AI about Summit Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Summit Therapeutics's total revenue?: Summit Therapeutics (SMMT) reported total revenue of $0 in Q4 2024.
What is the long-term trend for Summit Therapeutics's total revenue?: Over 2 years (2021 to 2023), Summit Therapeutics's total revenue has grown at a -100.0% compound annual growth rate (CAGR), from $1.81M to $0.